Characteristic | Alive (n = 67) | Death (n = 132) | All patients (n = 199) | Pa | OR UNI (95% CI) | Pb | OR MV (95% CI) | Pb | OR IWDRE (95% CI) | Pb |
---|---|---|---|---|---|---|---|---|---|---|
Age | ||||||||||
≤ 75 years | 40 (59.7) | 64 (48.5) | 104 |  |  |  |  |  |  |  |
> 75 years | 27 (40.3) | 68 (51.5) | 95 | 0.176 | 1.57 (0.87–2.86) | 0.136 | 1.63 (0.89–2.99) | 0.115 | 1.03 (0.56–1.91) | 0.924 |
Comorbidities | ||||||||||
Heart disease | 25 (37.3) | 56 (42.4) | 81 | 0.543 | 1.24 (0.68–2.26) | 0.488 |  |  |  |  |
Diabetes | 16 (23.9) | 33 (25.0) | 49 | 1.000 | 1.06 (0.54–2.11) | 0.863 |  |  |  |  |
Neurologic disease | 2 (3.0) | 9 (6.8) | 11 | 0.340 | 2.38 (0.5–11.33) | 0.277 |  |  |  |  |
Asthma | 2 (3.0) | 4 (3.0) | 6 | 1.000 | 1.02 (0.18–5.69) | 0.986 |  |  |  |  |
Chronic lung disease | 5 (7.5) | 12 (9.1) | 17 | 0.794 | 1.24 (0.42–3.68) | 0.698 |  |  |  |  |
Nephropathy | 4 (6.0) | 17 (12.9) | 21 | 0.151 | 2.33 (0.75–7.22) | 0.143 | 2.06 (0.65–6.57) | 0.22 | 2.2 (0.65–7.36) | 0.203 |
Critical presentation | 3 (4.5) | 60 (45.4) | 63 |  < 0.001 |  |  |  |  |  |  |
Southeast | 45 (67.2) | 76 (57.6) | 121 | 0.220 | 0.66 (0.36–1.23) | 0.192 | 0.64 (0.34–1.2) | 0.166 | 0.3 (0.15–0.61) | 0.001 |
Active ADT | 56 (83.6) | 100 (75.8) | 156 | 0.274 | 0.61 (0.29–1.31) | 0.208 | 0.63 (0.29–1.37) | 0.241 | 0.7 (0.38–1.31) | 0.263 |
Palliative treatment | 61 (91.0) | 118 (89.4) | 179 | 0.807 | 0.83 (0.3–2.27) | 0.715 |  |  |  |  |